Skip to main content
Mayinglong Pharmaceutical Group Co.,Ltd logo

Mayinglong Pharmaceutical Group Co.,Ltd — Investor Relations & Filings

Ticker · 600993 ISIN · CNE000001HN2 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 931 across all filing types
Latest filing 2005-05-23 AGM Information
Country CN China
Listing Shanghai Stock Exchange 600993

About Mayinglong Pharmaceutical Group Co.,Ltd

https://www.mayinglong.cn/

Mayinglong Pharmaceutical Group Co.,Ltd. is a long-established enterprise specializing in the research, development, and production of Traditional Chinese Medicine (TCM). Founded in 1582, the company is widely recognized for its expertise in proctology, maintaining a dominant market position with its signature hemorrhoid ointments and suppositories. Its product portfolio also includes ophthalmic preparations, dermatological treatments, and gastrointestinal medicines. The company integrates traditional medicinal formulas with modern manufacturing technologies to provide healthcare solutions. Beyond pharmaceuticals, Mayinglong has expanded into healthcare services, including specialized hospitals and personal care products, focusing on the integration of clinical treatment and health management.

Recent filings

Filing Released Lang Actions
董事会决议暨召开2004年年度股东大会的公告
AGM Information Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the company's fifth board meeting and the notice for the upcoming 2004 Annual General Meeting (AGM). It includes meeting date, agenda items such as approval of the 2004 board report, financial report, profit distribution plan, amendments to the articles of association, and appointment of auditors. It also provides procedural details for shareholders to attend and vote. The document does not contain the actual annual report or financial statements but rather the announcement and arrangements for the AGM where these will be discussed. The document length is 2099 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2005-05-23 Chinese
股东股权冻结公告
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the freezing of shareholder equity due to a legal dispute and court order. It does not contain financial statements, management discussion, or detailed report content. It is a regulatory announcement about shareholder equity status, fitting best under Regulatory Filings (RNS) as it does not match other specific categories like Major Shareholding Notification (MRQ) because it concerns freezing of shares, not ownership changes.
2005-05-13 Chinese
马 应 龙2005年第一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "武汉马应龙药业集团股份有限公司 600993 2005 第一季度报告" which translates to "Wuhan Mayinglong Pharmaceutical Group Co., Ltd. 2005 First Quarter Report." It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and management discussion and analysis for the first quarter of 2005. The report is unaudited as stated in the text. The presence of comprehensive financial statements and management analysis for a period shorter than a full fiscal year clearly identifies this as an Interim / Quarterly Report. The document length is 10,896 characters, which is substantial and contains actual financial data, not just an announcement or certification. Therefore, the correct classification is Interim / Quarterly Report (IR). Q1 2005
2005-04-19 Chinese
第五届董事会第六次会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the board of directors of Wuhan Mayinglong Pharmaceutical Group Co., Ltd. It details the decisions made at the sixth meeting of the fifth board, including approval of the 2004 annual financial statements, profit distribution plan, the 2004 annual report text and summary, and other corporate governance matters. The document includes voting results and specific financial figures for the 2004 fiscal year. The content is focused on board meeting resolutions rather than the full annual report itself. The document length is short (1646 characters) and it is an announcement of board meeting decisions, not the full annual report or financial statements. Therefore, it fits best under Board/Management Information (MANG) as it announces board meeting resolutions and decisions.
2005-03-22 Chinese
第五届监事会第四次会议决议公告
Regulatory Filings Classification · 95% confidence The document is an announcement of the resolutions passed at the fourth meeting of the fifth supervisory board of Wuhan Mayinglong Pharmaceutical Group Co., Ltd. It includes approval of the 2004 annual report text and summary, approval of write-offs of bad debts, and approval of changes in the location of certain fundraising projects. The document is short (538 characters) and serves as a meeting resolution announcement rather than the full annual report itself. It does not contain detailed financial statements or substantive financial data. Therefore, it is best classified as a Regulatory Filing (RNS), which is the fallback category for announcements that do not fit other specific categories.
2005-03-22 Chinese
马 应 龙2004年年度报告摘要
Annual Report Classification · 100% confidence The document is titled as the 2004 Annual Report Summary of Wuhan Mayinglong Pharmaceutical Group Co., Ltd. It contains detailed financial data including main accounting data, financial indicators, shareholder information, board and management details, business analysis, fundraising usage, audit opinions, and financial statements. The presence of comprehensive financial statements, audit opinions, and extensive business and financial analysis indicates this is a full annual report rather than a brief announcement or a partial report. The document length is substantial (15,000 characters), and it includes detailed financial tables and management discussion, consistent with an official yearly report covering company activity and full financial performance. Therefore, the document fits the definition of an Annual Report (10-K). FY 2004
2005-03-22 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.